Lastly, the study verified the specific role of LRRC59 in the gene model through cellular functional experiments, including Cell Counting Kit-8 (CCK8) proliferation assay and Transwell invasion assay, demonstrating that LRRC59 has a potential to serve as a prognostic biomarker and a potential target that can help in the treatment of COAD. The gene discussed is LRRC59; the disease is colon adenocarcinoma.